The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults

Research in Social and Administrative Pharmacy

Volumn 10, Issue 3, 2014, Pages 554-561

  de Oliveira Filho, Alfredo Dias ^a,b   Morisky, Donald E ^c   Neves, Sabrina Joany Felizardo ^b   Costa, Francisco A ^d   De Lyra, Divaldo Pereira ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hospital do Açúcar   (Brazil)

Author keywords

Cross cultural adaptation; Hypertension; Medication adherence; Morisky scale; Self reported adherence; Validation

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; BRAZIL; FEMALE; HUMAN; HYPERTENSION; LANGUAGE; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMETRY; QUESTIONNAIRE; VALIDATION STUDY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BRAZIL; FEMALE; HUMANS; HYPERTENSION; LANGUAGE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 84900517886     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.10.006     Document Type: Article

References (43)

1. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J Am Pharm Assoc 2003, 289:2363-2369.
2. Taylor J. Cardiology in Brazil: a country in development. Eur Heart J 2010 Jul, 31:1541-1542.
3. Picon R.V., Fuchs F.D., Moreira L.B., Riegel G., Fuchs S.C. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One 2012, 7(10):e48255. [Epub 2012 Oct 31]. 10.1371/journal.pone. 0048255.
4. Turnbull F., Neal B., Ninomiya T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008, 336:1121-1123.
5. Rosário T.M., Scala L.C.N.S., França G.V.A., Pereira M.R.G., Jardim P.C.B.V. Prevalência, controle e tratamento da hipertensão arterial sistêmica em Nobres, MT. Arq Bras Cardiol 2009, 93:672-678.
6. Pereira M., Lunet N., Azevedo A., Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009, 27:963-975.
7. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensão/Sociedade Brasileira de Nefrologia VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol 2010, 95(1 suppl1).
8. Munger M.A., Van Tassell B.W., LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007, 19(9):58.
9. Adherence to Long-term Therapies: Evidence for Action 2003, World Health Organization, Geneva, Switzerland. E. Sabaté (Ed.).
10. Adherence to Long-term Therapies: Evidence for Action 2003, World Health Organization, Geneva.
11. Carvalho A.L., Leopoldino R.W., da Silva J.E., da Cunha C.P. Adherence to drug treatment among registered users in the "HIPERDIA" Program in Teresina in the State of Piauí. Cien Saude Colet 2012, 17:1885-1892.
12. Rocha C.H., Oliveira A.P., Ferreira C., et al. Adesão à prescrição médica em idosos de Porto Alegre, RS. Ciênc Saúde Coletiva 2008, 13(suppl):703-710.
13. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005 Jun, 43:521-530.
14. Pittman D.G., Tao Z., Chen W., Stettin G.D. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care 2010, 16:568-576.
15. Corrao G., Parodi A., Nicotra F., et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011, 29:610-618.
16. Morgado M., Rolo S., Macedo A.F., Pereira L., Castelo-Branco M. Predictors of uncontrolled hypertension and antihypertensive medication nonadherence. JCardiovasc Dis Res 2010, 1:196-202.
17. Marcum Z.A., Zheng Y., Perera S., et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease. Rev Social Adm Pharm 2013, 9:817-827.
18. Vik S.A., Maxwell C.J., Hogan D.B. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004, 38:303-312.
19. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
20. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
21. Morisky D.E., Malotte C.K., Choi P., et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q 1990 Fall, 17:253-267.
22. Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008, 10:348-354.
23. Voils C.I., Hoyle R.H., Thorpe C.T., Maciejewski M.L., Yancy W.S. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol 2011 Mar, 64:250-254. [Epub 2010 Dec 30].
24. Shalansky S.J., Levy A.R., Ignaszewski A.P. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004, 38:1363-1368.
25. Unni E.J., Farris K.B. Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns 2011 May, 83(2):265-268.
26. Oliveira-Filho A.D., Barreto-Filho J.A., Neves S.J., Lyra Junior D.P. Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol 2012, 99:649-658.
27. Peat J.K. Health Science Research: A Handbook of Quantitative Methods 2001, Allen & Unwin, Crows Nest.
28. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432.
29. Beaton D., Bombardier C., Guillemin F., Ferraz M.B. Recommendations for the Cross-cultural Adaptation of Health Status Measures 2002, Available at:, Accessed 19.08.11. http://www.dash.iwh.on.ca/assets/images/pdfs/xculture2002.pdf.
30. Wild D., Grove A., Martin M., et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for translation and cultural adaptation. Value Health 2005, 8:94-104. ISPOR Task Force for Translation and Cultural Adaptation.
31. Krousel-Wood M., Islam T., Webber L.S., Re R.N., Morisky D.E., Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009, 15:59-66.
32. Añez C.R.R., Reis R.S., Petroski E.L. Versão brasileira do questionário "estilo de vida fantástico": tradução e validação para adultos jovens. Arq Bras Cardiol 2008, 91:102-109.
33. Bowling A. Research Methods in Health: Investigating Health and Health Services 2002, Open University Press, Buckingham.
34. Horne R., Hankins M., Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001, 10:135-140.
35. Hyre A.D., Krousel-Wood M.A., Muntner P., Kawasaki L., DeSalvo K.B. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 2007, 9:179-186.
36. Sakthong P., Chabunthom R., Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009 May, 43:950-957.
37. Al-Qazaz HKh, Hassali M.A., Shafie A.A., Sulaiman S.A., Sundram S., Morisky D.E. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010, 90:216-221.
38. Korb-Savoldelli V., Gillaizeau F., Pouchot J., et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. JClin Hypertens 2012, 14:429-434.
39. Streiner D.L., Norman G.R. Health Measurement Scales. A Practical Guide to Their Development and Use 2000, 54-68. Oxford University Press, New York. 2nd ed.
40. Moss S., Prosser H., Costello H., et al. Reliability and validity of the PAS-ADD checklist for detecting psychiatric disorders in adults with intellectual disability. J Intellect Disabil Res 1998, 42(Pt 2):173-183.
41. Reynolds R.C., Kamphaus R.W. Handbook of Psychological and Educational Assessment of Children 2003, The Guilford Press. 2nd ed.
42. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-209.
43. Lavsa S.M., Holzworth A., Ansani N.T. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003) 2011 Feb, 51:90-94.